It Appears They're in the Market for Something Tougher than a Time-Out | GenomeWeb

The Wall Street Journal reports that Congress members are pushing to transform the US FDA "by giving it broad powers to levy fines, order drug recalls and restrict drug-industry advertising," the article says. "The lawmakers say an FDA restructuring should build a much taller wall between the agency and the industry it regulates." The changes, if they happen, aren't expected to take place until next year.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.